REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2017

Jan 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2017-01-03

Reporting Person: Zoghbi Huda Y (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-03	Non-Qualified Stock Option (right to buy)	$376.69	A	2438	Acquired	2027-01-03	Common Stock (2438)	Direct

Footnotes

F1: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.